Drug Trial Radar · NCT04453085
An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)
Last checked: Nov 20, 2026Latest source record: Aug 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
14
Actual
Start
Oct 28, 2021
Primary completion
May 2, 2025
Study completion May 2, 2025
Sponsor
- Lead sponsor
- JCR Pharmaceuticals Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 1, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase I/II, open label, multicenter, multinational (Japan, Brazil and the US) extension study of JR-171-101 (NCT04227600) for the treatment of MPS I
Conditions
- Mucopolysaccharidosis I
Interventions
JR-171Drug
Intravenous (IV) infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with Adverse EventsTime frame: 156 weeks
- Incidence of abnormal laboratory test resultsTime frame: 156 weeks
- Incidence of abnormal laboratory test resultsTime frame: 156 weeks
- Incidence of abnormal laboratory test resultsTime frame: 156 weeks
- Incidence of abnormal laboratory test resultsTime frame: 156 weeks
- Incidence of abnormal vital signsTime frame: 156 weeks
- Incidence of abnormal vital signsTime frame: 156 weeks
- Incidence of abnormal vital signsTime frame: 156 weeks
- Incidence of abnormal vital signsTime frame: 156 weeks
- Incidence of abnormal EKG readingsTime frame: 156 weeks
- Number of participants with Adverse EventsTime frame: 156 weeks
- Number of participants with Adverse EventsTime frame: 156 weeks
- Number of participants with Adverse EventsTime frame: 156 weeks
Locations
6 sites in 3 countries. Site status is shown where the registry gives one.
UCSF Benioff Children's Hospital Oakland
Oakland, California
Hospital de Clínicas de Porto Alegre
Porto Alegre, Brazil
Instituto de Genética e Erros Inatos do Metabolismo - IGEIM
São Paulo, Brazil
Fukuoka Children's Hospital
Fukuoka, Japan
National Hospital Organization Kokura Medical Center
Kitakyushu, Japan
Osaka Metropolitan University Hospital
Osaka, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.